Radiobiological compensation: A case study of uterine cervix cancer with concurrent chemotherapy
- Centro Estatal de Cancerologia de Durango, Victoria de Durango, Durango (Mexico)
The case of a patient diagnosed with uterine cervix cancer is presented as an example of the clinical application of the radiobiological compensation method implemented at Centro Estatal de Cancerologia de Durango. Radiotherapy treatment was initially modified to compensate for the chemotherapy component and, as medical complications arose during treatment delivery resulting in an 18 days gap, new compensation followed. All physical and radiobiological assumptions to calculate the Biologically Effective Dose in the external beam and brachytherapy parts of the treatment are presented. Good local control of the tumor was achieved, the theoretical tolerance limits for the organs at risk were not surpassed and the patient manifested no extensive morbidity.
- OSTI ID:
- 22075685
- Journal Information:
- AIP Conference Proceedings, Vol. 1494, Issue 1; Conference: 12. Mexican symposium on medical physics, Oaxaca (Mexico), 16-19 Mar 2012; Other Information: (c) 2012 American Institute of Physics; Country of input: International Atomic Energy Agency (IAEA); ISSN 0094-243X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Six fractions per week of external beam radiotherapy and high-dose-rate brachytherapy for carcinoma of the uterine cervix: A phase I/II study
The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation